AMN Healthcare (AMN) released Q2 2025 financial results, reporting $658 million in revenue and $58.3 million in adjusted EBITDA. The company faced a GAAP loss of $3.02 per share but achieved an adjusted EPS of $0.30. Revenue declined 11% YoY, with the Nurse and Allied Solutions segment down 14% and the Physician and Leadership Solutions segment down 6%. Strong cash flow reduced debt by $80 million, though the company anticipates a challenging Q3 with projected revenue declines. Strategic initiatives and technology advancements remain central to its outlook.

AMN Healthcare Services (AMN) reported Q2 earnings of $0.3 per share, exceeding the Zacks Consensus Estimate of $0.17, and revenue of $658.18 million, surpassing the Zacks Consensus Estimate by 0.87%. The company also posted a Zacks Rank #3 (Hold) based on earnings estimate revisions. Aclarion, Inc. (ACON) is expected to report a quarterly loss of $2.26 per share, up 99.8% year-over-year.

The average starting salary for physicians in the U.S. has exceeded $400,000, with orthopedic surgeons at $576,000 and pediatricians at $258,000. This follows a report by AMN Healthcare and the American Medical Group Association (AMGA), which attributes rising salaries to physician shortages, an aging population, and increased demand for specialists. Nurse practitioners also saw a 9.6% salary increase to $180,000.

AMN Healthcare Services, Inc. (NYSE: AMN) reported second quarter 2025 financial results, including $658 million in revenue, Adjusted EBITDA of $58.3 million, and a GAAP loss of ($3.02) per share. The company sold its Smart Square nurse scheduling software for $75 million, which reduced annualized revenue and adjusted EBITDA by $17 million and $6 million, respectively. CEO Cary Grace highlighted progress in serving healthcare clients despite challenges from an uncertain policy environment.

Coherent Market Insights Reports released a detailed analysis of the Healthcare Staffing Market 2025, highlighting trends, growth dynamics, and forecasts through 2032. The report evaluates market drivers, segmentation, regional outlooks, and key players, offering insights for stakeholders and investors.